Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velusetrag Effects on Gastric Emptying in Gastroparesis
NCT01718938Phase 2Completed
- Sponsor
- Theravance Biopharma, Inc.
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of velusetrag in gastroparesis (4 arms), sponsored by Theravance Biopharma, Inc. Primary endpoint: Gastric emptying half time at Week 5. Started Dec 2012; status: completed.
02
Drugs
velusetrag
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT01718938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718938.